Endocrine profile following stimulation with recombinant follicle stimulating hormone and luteinizing hormone versus highly purified human menopausal gonadotropin

Reproductive Biology and Endocrinology

Volumn 12, Issue 1, 2014, Pages

  Requena, Antonio ^a   Cruz, María ^a   Ruiz, Francisco J ^a   García Velasco, Juan A ^a,b  

^a INSTITUTO VALENCIANO DE INFERTILIDAD   (Spain)

^b UNIVERSIDAD REY JUAN CARLOS   (Spain)

Author keywords

Follicular growth; FSH; hCG; LH; Steroid profile

Indexed keywords

ADULT; CHORIONIC GONADOTROPIN; ENDOCRINE SYSTEM; FEASIBILITY STUDIES; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; LUTEINIZING HORMONE; MENOTROPINS; OOCYTE DONATION; PILOT PROJECTS; PREGNANCY; PREGNANCY RATE; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; YOUNG ADULT;

EID: 84892961225     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-12-10     Document Type: Article

References (20)

1. Andersen AN, Devroey P, Arce JC. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Hum Reprod 2006, 21:3217-3227. 10.1093/humrep/del284, 16873892.
2. Devroey P, Pellicer A, Nyboe Andersen A, Arce JC. Menopur in GnRH Antagonist Cycles with Single Embryo Transfer Trial Group A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer. Fertil Steril 2012, 97:561-571. 10.1016/j.fertnstert.2011.12.016, 22244781, Menopur in GnRH Antagonist Cycles with Single Embryo Transfer Trial Group.
3. Van Wely M, Westergaard LG, Bossuyt PMM, Van der Veen F. Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles (Review), Cochrane Database of Systematic reviews 2003, The Cochrane Collaboration, Published by John Wiley and sons, Ltd.
4. Wolfenson C, Groisman J, Couto AS, Hedenfalk M, Cortvrindt RG, Smitz JE, Jespersen S. Batch-to-batch consistency of human-derived gonadotrophin preparations compared with recombinant preparations. Reprod Biomed Online 2005, 10:442-454. 10.1016/S1472-6483(10)60819-X, 15901450.
5. Smitz J, Andersen AN, Devroey P, Arce JC. MERIT Group Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients. Hum Reprod 2007, 22:676-687. MERIT Group.
6. Koulianos G. Gonadotropins in the treatment of infertility. US Obstetrics & Gynecology 2009, 4:29-36.
7. Platteau P, Nyboe Andersen A, Loft A, Smitz J, Danglas P, Devroey P. Highly purified HMG versus recombinant FSH for ovarian stimulation in IVF cycles. Reprod Biomed Online 2008, 17:190-198. 10.1016/S1472-6483(10)60194-0, 18681992.
8. Orme B. Getting started with conjoint analysis: strategies for product design and pricing research 2006, Madison, WI (USA): Research Publishers, LLC.
9. Garrido N, Zuzuarregui JL, Meseguer M, Simon C, Remohi J, Pellicer A. Sperm and oocyte donor selection and management: experience of a 10 year follow-up of more than 2100 candidates. Hum Reprod 2002, 17:3142-3148. 10.1093/humrep/17.12.3142, 12456614.
10. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004, 81:19-25. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group.
11. Alikani M, Calderon G, Tomkin G, Garrisi J, Kokot M, Cohen J. Cleavage anomalies in early human embryos and survival after prolonged culture in-vitro. Hum Reprod 2000, 15:2634-2643. 10.1093/humrep/15.12.2634, 11098037.
12. Remohi J, Gallardo E, Guanes PP, Simon C, Pellicer A. Donor-recipient synchronization and the use of gonadotrophin-releasing hormone agonists to avoid the premature luteinizing hormone surge in oocyte donation. Hum Reprod 1995, 10(Suppl 2):84-90. 10.1093/humrep/10.suppl_2.84, 8745305.
13. Yding AC. Effect of FSH and its different isoforms on maturation of oocytes from pre-ovulatory follicles. Reprod Biomed Online 2002, 5:232-239. 10.1016/S1472-6483(10)61826-3, 12470520.
14. Al-Inany HG, Abou-Setta AM, Aboulghar MA, Mansour RT, Serour GI. Efficacy and safety of human menopausal gonadotrophins versus recombinant FSH: a meta-analysis. Reprod Biomed Online 2008, 16:81-88. 10.1016/S1472-6483(10)60559-7, 18252052.
15. Coomarasamy A, Afnan M, Cheema D, van der Veen F, Bossuyt PM, van Wely M. Urinary hMG versus recombinant FSH for controlled ovarian hyperstimulation following an agonist long down-regulation protocol in IVF or ICSI treatment: a systematic review and meta-analysis. Hum Reprod 2008, 23:310-315.
16. Casarini L, Lispi M, Longobardi S, Milosa F, La Marca A, Tagliasacchi D, Pignatti E, Simoni M. LH and hCG action on the same receptor results in quantitatively and qualitatively different intracellular signalling. PLoS One 2012, 7:e46682. 10.1371/journal.pone.0046682, 3465272, 23071612.
17. Ziebe S, Lundin K, Janssens R, Helmgaard L, Arce JC. MERIT (Menotrophin vs Recombinant FSH in vitro Fertilisation Trial) Group Influence of ovarian stimulation with HP-hMG or recombinant FSH on embryo quality parameters in patients undergoing IVF. Hum Reprod 2007, 22:2404-2413. 10.1093/humrep/dem221, 17640944, MERIT (Menotrophin vs Recombinant FSH in vitro Fertilisation Trial) Group.
18. Pacchiarotti A, Sbracia M, Frega A, Selman H, Rinaldi L, Pacchiarotti A. Urinary hMG (Menopur) versus recombinant FSH plus recombinant LH (Pergoveris) in IVF: a multicenter, prospective, randomized controlled trial. Fertil Steril 2010, 94:2467-2469. 10.1016/j.fertnstert.2010.04.035, 20537626.
19. Eldar-Geva T, Margalioth EJ, Brooks B, Algur N, Zylber-Haran E, Diamant YZ. The origin of serum progesterone during the follicular phase of menotropin-stimulated cycles. Hum Reprod 1998, 13:9-14.
20. Yding Andersen C, Bungum L, Nyboe Andersen A, Humaidan P. Preovulatory progesterone concentration associates significantly to follicle number and LH concentration but not to pregnancy rate. Reprod Biomed Online 2011, 23:187-195. 10.1016/j.rbmo.2011.04.003, 21665546.